A. Colatrella et al. in their paper titled “Comparison of insulin lispro protamine suspension with NPH insulin in pregnant women with type 2 and gestational diabetes mellitus: maternal and perinatal outcomes” have retrospectively compared maternal and perinatal outcomes of insulin lispro protamine suspension with neutral protamine Hagedorn (NPH) insulin in 25 pregnant women with T2DM and 64 with gestational diabetes (GDM). The gene discussed is INS; the disease is type 2 diabetes mellitus.